Ganaxolone News
Ganaxolone currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Ganaxolone with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Ztalmy is indicated for the adjunctive treatment of epileptic seizures associated with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) in patients 2 to 17 years of age. Ztalmy may be...
- Evidence level: L5
- Predicted indications (20):
- alcohol withdrawal delirium (94.8%)
- hallucinogen abuse (93.1%)
- barbiturate abuse (93.1%)
- antidepressant type abuse (93.1%)
- phencyclidine abuse (82.8%)
- alcohol withdrawal (81.8%)
- autism spectrum disorder (79.3%)
- gaze palsy, familial horizontal, with progressive scoliosis (77.0%)
- asperger syndrome, susceptibility to (76.1%)
- autism susceptibility 1 (75.5%)
- drug dependence (74.7%)
- alcohol-related disorders (73.3%)
- amelocerebrohypohidrotic syndrome (73.1%)
- Wernicke-Korsakoff syndrome (72.7%)
- autism, susceptibility to (72.0%)
- intellectual disability (71.0%)
- adenosarcoma (70.7%)
- uterine ligament adenosarcoma (70.7%)
- 16q24.3 microdeletion syndrome (70.1%)
- chromosome 15q11.2 deletion syndrome (69.9%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.